Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
CAS Number: 1415800-43-9
10 mM SB431542
Effect of DNA damage response by quinazolinone analogue HMJ-38 on human umbilical vein endothelial cells: Evidence for γH2A
2-hydroxyglutarate (2HG)
Ledipasvir - CAS# 1256388-51-8 0153 CAS Number: 1415800-43-9Ledipasvir, also known as GS 5885, CAS No. 1256388 51 8, is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg sofosbuvir 400 mg (trade name Harvoni). The ledipasvir sofosbuvir combination is a direct acting antiviral agent that interferes with HCV replication and can be used to treat
US$ 63.00
US$ 42.00
US$ 104.50
US$ 48.00
US$ 50.00
US$ 60.00
US$ 20.00
US$ 16.00